+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Migraine Drug"

Market Spotlight: Migraine - Product Thumbnail Image

Market Spotlight: Migraine

  • Report
  • August 2020
  • 56 Pages
  • Global
Latin America Migraine Drugs Market 2023-2027 - Product Thumbnail Image

Latin America Migraine Drugs Market 2023-2027

  • Report
  • November 2022
  • 120 Pages
  • Latin America
From
Global Migraine Therapeutics Market 2021-2025 - Product Thumbnail Image

Global Migraine Therapeutics Market 2021-2025

  • Report
  • March 2021
  • 120 Pages
  • Global
From
US Migraine Market and Competitive Landscape - 2022 - Product Thumbnail Image

US Migraine Market and Competitive Landscape - 2022

  • Report
  • August 2022
  • United States
From
Global Migraine Clinical Trial Pipeline Highlights - 2022 - Product Thumbnail Image

Global Migraine Clinical Trial Pipeline Highlights - 2022

  • Report
  • August 2022
  • Global
From
Global Migraine Market and Competitive Landscape - 2021 - Product Thumbnail Image

Global Migraine Market and Competitive Landscape - 2021

  • Report
  • August 2021
  • Global
From
Europe Migraine Market and Competitive Landscape - 2021 - Product Thumbnail Image

Europe Migraine Market and Competitive Landscape - 2021

  • Report
  • August 2021
  • Europe
From
Global Migraine Epidemiology and Patient Flow - 2021 - Product Thumbnail Image

Global Migraine Epidemiology and Patient Flow - 2021

  • Report
  • February 2021
  • Global
From
Migraine - Global Clinical Trials Review, H2, 2021 - Product Thumbnail Image

Migraine - Global Clinical Trials Review, H2, 2021

  • Clinical Trials
  • November 2021
  • 985 Pages
  • Global
From
Migraine - Global Drug Forecast and Market Analysis to 2030 - Product Thumbnail Image

Migraine - Global Drug Forecast and Market Analysis to 2030

  • Report
  • November 2021
  • 131 Pages
  • Global
From
Migraine - Epidemiology Forecast to 2030 - Product Thumbnail Image

Migraine - Epidemiology Forecast to 2030

  • Report
  • July 2021
  • 38 Pages
  • Global
From
Migraine - Competitive Landscape in 2021 - Product Thumbnail Image

Migraine - Competitive Landscape in 2021

  • Report
  • March 2021
  • 52 Pages
  • Global
From
Analyzing the Global CNS Market 2018 - Product Thumbnail Image

Analyzing the Global CNS Market 2018

  • Report
  • April 2018
  • Global
From
Global Non-steroidal Anti-inflammatory Drugs Market Size, Share & Industry Trends Analysis Report By Route of Administration (Oral, Topical and Others), By Distribution Channel, By Route of Disease Indication, By Regional Outlook and Forecast, 2022 - 2028 - Product Thumbnail Image

Global Non-steroidal Anti-inflammatory Drugs Market Size, Share & Industry Trends Analysis Report By Route of Administration (Oral, Topical and Others), By Distribution Channel, By Route of Disease Indication, By Regional Outlook and Forecast, 2022 - 2028

  • Report
  • July 2022
  • 225 Pages
  • Global
From
Europe Non-steroidal Anti-inflammatory Drugs Market Size, Share & Industry Trends Analysis Report By Route of Administration (Oral, Topical and Others), By Distribution Channel, By Route of Disease Indication, By Country and Growth Forecast, 2022 - 2028 - Product Thumbnail Image

Europe Non-steroidal Anti-inflammatory Drugs Market Size, Share & Industry Trends Analysis Report By Route of Administration (Oral, Topical and Others), By Distribution Channel, By Route of Disease Indication, By Country and Growth Forecast, 2022 - 2028

  • Report
  • July 2022
  • 95 Pages
  • Europe
From
North America Non-steroidal Anti-inflammatory Drugs Market Size, Share & Industry Trends Analysis Report By Route of Administration (Oral, Topical and Others), By Distribution Channel, By Route of Disease Indication, By Country and Growth Forecast, 2022 - 2028 - Product Thumbnail Image

North America Non-steroidal Anti-inflammatory Drugs Market Size, Share & Industry Trends Analysis Report By Route of Administration (Oral, Topical and Others), By Distribution Channel, By Route of Disease Indication, By Country and Growth Forecast, 2022 - 2028

  • Report
  • July 2022
  • 84 Pages
  • North America
From
LAMEA Non-steroidal Anti-inflammatory Drugs Market Size, Share & Industry Trends Analysis Report By Route of Administration (Oral, Topical and Others), By Distribution Channel, By Route of Disease Indication, By Country and Growth Forecast, 2022 - 2028 - Product Thumbnail Image

LAMEA Non-steroidal Anti-inflammatory Drugs Market Size, Share & Industry Trends Analysis Report By Route of Administration (Oral, Topical and Others), By Distribution Channel, By Route of Disease Indication, By Country and Growth Forecast, 2022 - 2028

  • Report
  • July 2022
  • 95 Pages
  • Middle East, Africa
From
Asia Pacific Non-steroidal Anti-inflammatory Drugs Market Size, Share & Industry Trends Analysis Report By Route of Administration (Oral, Topical and Others), By Distribution Channel, By Route of Disease Indication, By Country and Growth Forecast, 2022 - 2028 - Product Thumbnail Image

Asia Pacific Non-steroidal Anti-inflammatory Drugs Market Size, Share & Industry Trends Analysis Report By Route of Administration (Oral, Topical and Others), By Distribution Channel, By Route of Disease Indication, By Country and Growth Forecast, 2022 - 2028

  • Report
  • July 2022
  • 96 Pages
  • Asia Pacific
From
Migraine - Pipeline Review, H2 2020 - Product Thumbnail Image

Migraine - Pipeline Review, H2 2020

  • Drug Pipelines
  • November 2020
  • 342 Pages
  • Global
From
Migraine Therapeutics Market: Global Industry Analysis, Trends, Market Size, and Forecasts up to 2030 - Product Thumbnail Image

Migraine Therapeutics Market: Global Industry Analysis, Trends, Market Size, and Forecasts up to 2030

  • Report
  • March 2023
  • 100 Pages
  • Global
From
Loading Indicator

The Migraine Drug market is a subset of the Central Nervous System Drugs market, which includes drugs used to treat neurological disorders. Migraine drugs are used to treat the symptoms of migraine headaches, such as nausea, vomiting, and sensitivity to light and sound. These drugs can be divided into two categories: abortive and preventive. Abortive drugs are taken at the onset of a migraine attack to reduce the severity of symptoms, while preventive drugs are taken on a regular basis to reduce the frequency of migraine attacks. Common abortive drugs include triptans, ergot alkaloids, and non-steroidal anti-inflammatory drugs (NSAIDs). Common preventive drugs include beta-blockers, anticonvulsants, and serotonin receptor agonists. Some companies in the Migraine Drug market include GlaxoSmithKline, Pfizer, Novartis, Merck, and Allergan. Show Less Read more